<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Peripheral lymphadenopathy in children: Etiology</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Peripheral lymphadenopathy in children: Etiology</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Peripheral lymphadenopathy in children: Etiology</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kenneth L McClain, MD, PhD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jan E Drutz, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sheldon L Kaplan, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alberto S Pappo, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Diane Blake, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 28, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Lymphadenopathy is common. It is usually not clinically important in and of itself. However, it can represent serious underlying disease. The challenge for clinicians is to avoid aggressive evaluation and biopsy of most children, while making timely, specific diagnoses in children with serious underlying disease.</p><p>The causes of peripheral lymphadenopathy in children will be reviewed here  (<a class="graphic graphic_table graphicRef81033 graphicRef66847" href="/d/graphic/81033.html" rel="external">table 1A-B</a> and <a class="graphic graphic_table graphicRef71073" href="/d/graphic/71073.html" rel="external">table 2</a>). The information is intended to provide a framework for the approach to the evaluation of peripheral lymphadenopathy in children and to supplement clinical judgment in the absence of research that directly addresses how children with unexplained lymphadenopathy should be evaluated.</p><p>The approach to the child with peripheral lymphadenopathy, cervical lymphadenitis, and the causes and evaluation of peripheral lymphadenopathy in adults are discussed separately. (See  <a class="medical medical_review" href="/d/html/5982.html" rel="external">"Cervical lymphadenitis in children: Etiology and clinical manifestations"</a> and  <a class="medical medical_review" href="/d/html/2867.html" rel="external">"Peripheral lymphadenopathy in children: Evaluation and diagnostic approach"</a> and  <a class="medical medical_review" href="/d/html/8386.html" rel="external">"Evaluation of peripheral lymphadenopathy in adults"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">ANATOMY AND DEFINITIONS</span><span class="headingEndMark"> — </span>The location of peripheral lymph node groups is shown schematically in the figures  (<a class="graphic graphic_figure graphicRef69528" href="/d/graphic/69528.html" rel="external">figure 1</a> and <a class="graphic graphic_figure graphicRef57451" href="/d/graphic/57451.html" rel="external">figure 2</a>). Normal lymph nodes in most regions usually are less than 1 cm in their longest diameter; normal lymph nodes in the epitrochlear region usually are less than 0.5 cm in diameter, and normal lymph nodes in the inguinal region usually are less than 1.5 cm in diameter. Normal lymph nodes tend to be larger in childhood (ages 2 to 10 years) than later in life. Lymph nodes often are palpable in the inguinal region in healthy individuals, perhaps because chronic trauma and infection are so common in the lower extremities. Lymph nodes also may be palpable in the neck (particularly submandibular lymph nodes) because of previous head and neck infections.</p><p class="headingAnchor" id="H3"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Lymph node enlargement may be caused by [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Replication of cells within the node in response to antigenic stimuli (as occurs in infections or serum sickness) or as a result of malignant transformation</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Entry of large numbers of cells exogenous to the node (eg, neutrophils or metastatic neoplastic cells)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Deposition of foreign material within histiocytic cells of the node (as occurs in lipid storage diseases)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Vascular engorgement and edema secondary to local cytokine release</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Suppuration secondary to tissue necrosis</p><p></p><p class="headingAnchor" id="H4"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Children frequently have palpable lymph nodes because their immune systems are being activated by environmental antigens and the common organisms to which they are exposed. The prevalence of lymphadenopathy in the various lymph node groups varies with age and site [<a href="#rid2">2,3</a>]. Small occipital and postauricular nodes, for example, are common in infants, but not in older children [<a href="#rid2">2</a>]. In contrast, cervical and inguinal nodes are more common after two years of age than in the first six months of life [<a href="#rid2">2,3</a>]. Epitrochlear and supraclavicular adenopathy are uncommon at any age.</p><p>In one review, 44 percent of children younger than five years who were seen for well-child visits and 64 percent of those seen for "sick" visits had lymphadenopathy [<a href="#rid2">2</a>]. Most of the children with adenopathy detected at "sick" visits were between three and five years of age.</p><p>Many patients with unexplained lymphadenopathy (and their clinicians) are concerned about the possibility of malignancy. The prevalence of malignancy among patients seen in the primary care setting is relatively low [<a href="#rid4">4,5</a>]. In contrast, the prevalence of malignancy in lymph node biopsies performed in pediatric referral centers ranges from 13 to 27 percent [<a href="#rid3">3,6,7</a>].</p><p>In the largest of these series, 239 children underwent peripheral lymph node biopsies for evaluation of lymphadenopathy [<a href="#rid3">3</a>]. The following etiologies were noted:</p><p class="bulletIndent1"><span class="glyph">●</span>Reactive hyperplasia of undetermined cause – 52 percent</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Granulomatous disease (eg, cat scratch disease, atypical mycobacteria, <em>Mycobacterium tuberculosis</em>, fungal infections, or Langerhans cell histiocytosis [histiocytosis X]) – 32 percent</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neoplastic disease – 13 percent; among these two-thirds had Hodgkin disease</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chronic dermatopathic or bacterial infections – 3 percent</p><p></p><p>In another series of 159 children with cervical lymphadenopathy who underwent excisional biopsy for size &gt;1.5 cm, persistence for &gt;3.5 months (median time), and unresponsiveness to antimicrobial therapy, 40 percent were diagnosed with reactive hyperplasia, 39 percent with lymphoma, and 16 percent with granulomatous lymphadenitis [<a href="#rid8">8</a>].</p><p>A systematic review of causes of cervical lymphadenopathy in 2687 children from Italy, Turkey, India, Egypt, and Nigeria provides a more global view of causes [<a href="#rid9">9</a>]. Sixty-eight percent of children had nonspecific diagnoses, 9 percent had Epstein-Barr virus, 4.7 percent had malignancies, 4 percent had granulomatous diseases, 4 percent had cytomegalovirus, and 3 percent had group A beta-hemolytic <em>Streptococcus</em>. Remaining causes each accounted for less than 1 percent of cases. Among the 126 children with malignancies, 46 percent were not specified, 27 percent had non-Hodgkin lymphoma, 21 percent had Hodgkin lymphoma, and 2.4 percent had Langerhans cell histiocytosis.</p><p class="headingAnchor" id="H5"><span class="h1">GENERAL CLASSIFICATION</span><span class="headingEndMark"> — </span>Lymphadenopathy can be caused by a vast array of diseases  (<a class="graphic graphic_table graphicRef81033 graphicRef66847" href="/d/graphic/81033.html" rel="external">table 1A-B</a> and <a class="graphic graphic_table graphicRef71073" href="/d/graphic/71073.html" rel="external">table 2</a>) and drugs  (<a class="graphic graphic_table graphicRef61046" href="/d/graphic/61046.html" rel="external">table 3</a>) [<a href="#rid10">10,11</a>]. Some presentations suggest a specific disease process, whereas a few diseases present predominantly with lymphadenopathy.</p><p>It is clinically useful to classify the causes of lymphadenopathy according to whether the lymphadenopathy is localized (in only one region, such as the neck or axilla)  (<a class="graphic graphic_table graphicRef71073" href="/d/graphic/71073.html" rel="external">table 2</a>) or generalized (occurring in more than one noncontiguous region)  (<a class="graphic graphic_table graphicRef81033 graphicRef66847" href="/d/graphic/81033.html" rel="external">table 1A-B</a>) [<a href="#rid11">11</a>].</p><p>Conditions that can mimic lymphadenopathy are discussed below. (See <a class="local">'Mimics of lymphadenopathy'</a> below.)</p><p class="headingAnchor" id="H6"><span class="h1">LOCALIZED LYMPHADENOPATHY</span><span class="headingEndMark"> — </span>Localized lymphadenopathy is present in only one region, such as the neck or axilla. It is usually caused by an infection  (<a class="graphic graphic_table graphicRef71073" href="/d/graphic/71073.html" rel="external">table 2</a>).</p><p>Selected causes of localized lymphadenopathy are discussed below. The evaluation and management of unexplained nonsupraclavicular localized lymphadenopathy are discussed separately. (See  <a class="medical medical_review" href="/d/html/2867.html" rel="external">"Peripheral lymphadenopathy in children: Evaluation and diagnostic approach", section on 'Localized adenopathy'</a>.)</p><p class="headingAnchor" id="H7"><span class="h2">Cervical</span><span class="headingEndMark"> — </span>The anterior cervical lymph nodes are enlarged in a variety of infections of the head and neck and in systemic infections such as toxoplasmosis, Epstein-Barr virus, or cytomegalovirus infection. Only one-quarter of patients with enlarged cervical nodes have another serious disease, which most often is mycobacterial. Upper posterior cervical lymphadenopathy rarely is associated with significant diseases in children [<a href="#rid10">10,11</a>].</p><p>In considering the causes of cervical lymphadenopathy, it is helpful to distinguish between acute (develops over a few days) and subacute/chronic (develops over weeks to months) lymphadenopathy and whether the adenopathy is unilateral or bilateral. (See  <a class="medical medical_review" href="/d/html/5982.html" rel="external">"Cervical lymphadenitis in children: Etiology and clinical manifestations"</a>.)</p><p>Inflamed cervical nodes that develop over a few days and progress to fluctuation, especially in children, typically are caused by staphylococcal  (<a class="graphic graphic_picture graphicRef74121" href="/d/graphic/74121.html" rel="external">picture 1</a>) and streptococcal infection [<a href="#rid12">12</a>]. Acute inflamed cervical nodes usually are unilateral. The source of infection may be unapparent even after careful examination. Treatment typically begins first with a course of antibiotics, but incision and drainage may be indicated. Antimicrobial treatment of cervical lymphadenitis is discussed separately. (See  <a class="medical medical_review" href="/d/html/6061.html" rel="external">"Cervical lymphadenitis in children: Diagnostic approach and initial management", section on 'Initial laboratory evaluation and management'</a>.)</p><p>Fluctuant cervical nodes that develop over weeks to months without significant inflammation or tenderness suggest infection with <em>M. tuberculosis</em>, atypical mycobacteria, or <em>Bartonella henselae</em>, the agent of cat scratch disease. Cat scratch disease is discussed separately. (See  <a class="medical medical_review" href="/d/html/5532.html" rel="external">"Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease"</a>.)</p><p>Mycobacterial infections can present with lymphadenopathy alone, especially in the neck (scrofula). <em>M. avium</em> complex and <em>M. scrofulaceum </em>account for most cases in children [<a href="#rid13">13,14</a>]. Nodes typically are nontender, enlarge over weeks to months without prominent systemic symptoms, and can progress to matting and fluctuation  (<a class="graphic graphic_picture graphicRef69475" href="/d/graphic/69475.html" rel="external">picture 2</a>). (See  <a class="medical medical_review" href="/d/html/86045.html" rel="external">"Nontuberculous mycobacterial lymphadenitis in children", section on 'Clinical features'</a>.)</p><p>Hard nodes, often associated with cancer in adults, are found infrequently in children. The nodes involved with Hodgkin disease are rubbery and difficult to differentiate from hyperplastic nodes or nodes caused by granulomatous disease. (See  <a class="medical medical_review" href="/d/html/6246.html" rel="external">"Overview of Hodgkin lymphoma in children and adolescents"</a>.)</p><p class="headingAnchor" id="H8"><span class="h2">Supraclavicular</span><span class="headingEndMark"> — </span>Supraclavicular (or lower cervical)  (<a class="graphic graphic_figure graphicRef69528" href="/d/graphic/69528.html" rel="external">figure 1</a>) lymphadenopathy is associated with a high risk of malignancy (up to 75 percent) in children [<a href="#rid7">7,11</a>]. Right supraclavicular adenopathy is associated with cancer of the mediastinal lymph nodes. Left supraclavicular adenopathy ("Virchow's node") suggests intra-abdominal malignancy, most often lymphoma or metastatic disease (eg, neuroblastoma) [<a href="#rid15">15</a>].</p><p class="headingAnchor" id="H9"><span class="h2">Axillary</span><span class="headingEndMark"> — </span>The axillary nodes receive drainage from the arm, thoracic wall, and breast. Infections, including cat scratch disease, are common causes of axillary lymphadenopathy. In one series of 31 children who underwent axillary node biopsies, 11 (35 percent) had reactive hyperplasia and five (16 percent) had cat scratch disease [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/d/html/5532.html" rel="external">"Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease"</a>.)</p><p class="headingAnchor" id="H10"><span class="h2">Inguinal</span><span class="headingEndMark"> — </span>Inguinal lymphadenopathy in children usually is not associated with a specific cause unless the nodes are very large (&gt;3 cm). The inguinal lymph nodes drain the lower abdomen (including the umbilicus), genitalia (penis, scrotum, vulva), perineum, leg, and buttocks  (<a class="graphic graphic_table graphicRef71073" href="/d/graphic/71073.html" rel="external">table 2</a>) [<a href="#rid16">16,17</a>].</p><p class="headingAnchor" id="H11"><span class="h2">Epitrochlear</span><span class="headingEndMark"> — </span>Palpable epitrochlear nodes  (<a class="graphic graphic_figure graphicRef57451" href="/d/graphic/57451.html" rel="external">figure 2</a>) are often pathologic in children. However, many biopsied nodes show only hyperplasia if they are associated with cuts or abrasions and there are no other signs suggestive of malignancy. The differential diagnosis for epitrochlear lymphadenopathy includes infections of the forearm or hand, leukemia, lymphoma, and atypical mycobacterial infections. (See  <a class="medical medical_review" href="/d/html/6244.html" rel="external">"Overview of the clinical presentation and diagnosis of acute lymphoblastic leukemia/lymphoma in children"</a>.)</p><p class="headingAnchor" id="H12"><span class="h1">GENERALIZED LYMPHADENOPATHY</span><span class="headingEndMark"> — </span>Generalized lymphadenopathy is present in two or more noncontiguous regions. It may be a feature of numerous systemic diseases, many of which are recognized by other clinical findings  (<a class="graphic graphic_table graphicRef81033 graphicRef66847" href="/d/graphic/81033.html" rel="external">table 1A-B</a>). Several of these diseases are discussed below.</p><p class="headingAnchor" id="H13"><span class="h2">Systemic infection</span><span class="headingEndMark"> — </span>Systemic bacterial or viral illnesses are the most common causes of generalized adenopathy [<a href="#rid14">14</a>]. Common viral causes of generalized lymphadenopathy include Epstein-Barr virus or cytomegalovirus mononucleosis, rubella, and measles (in parts of the world where rubella and measles are endemic).</p><p class="headingAnchor" id="H14"><span class="h3">Mononucleosis</span><span class="headingEndMark"> — </span>Classic infectious mononucleosis is characterized by the triad of moderate to high fever, pharyngitis, and lymphadenopathy. A characteristic distribution of lymph node involvement occurs; typically it is symmetric and involves the posterior cervical more than the anterior cervical chain. The posterior cervical nodes are deep to the sternocleidomastoid muscles  (<a class="graphic graphic_figure graphicRef69528" href="/d/graphic/69528.html" rel="external">figure 1</a>). Lymphadenopathy also may be present in the axillary and inguinal areas, which helps to distinguish infectious mononucleosis from other causes of pharyngitis. The lymph nodes are kidney-shaped and may be large. Lymphadenopathy peaks in the first week and then gradually subsides over two to three weeks. (See  <a class="medical medical_review" href="/d/html/8318.html" rel="external">"Infectious mononucleosis"</a>.)</p><p class="headingAnchor" id="H15"><span class="h3">HIV</span><span class="headingEndMark"> — </span>Lymphadenopathy is common in primary human immunodeficiency virus (HIV) infection. Nontender adenopathy primarily involving the axillary, cervical, and occipital nodes develops in the majority of individuals during the second week of acute symptomatic HIV infection, concomitant with the emergence of a specific immune response to HIV [<a href="#rid14">14</a>]. The nodes decrease in size after the acute presentation, but a modest degree of adenopathy tends to persist. (See  <a class="medical medical_review" href="/d/html/5963.html" rel="external">"Pediatric HIV infection: Classification, clinical manifestations, and outcome", section on 'Clinical manifestations'</a>.)</p><p class="headingAnchor" id="H16"><span class="h3">Miliary tuberculosis</span><span class="headingEndMark"> — </span>Miliary tuberculosis is an important consideration in patients with generalized lymphadenopathy. Miliary tuberculosis can be mistaken for malignancy. (See  <a class="medical medical_review" href="/d/html/8024.html" rel="external">"Clinical manifestations, diagnosis, and treatment of miliary tuberculosis"</a> and  <a class="medical medical_review" href="/d/html/8029.html" rel="external">"Epidemiology and pathology of miliary and extrapulmonary tuberculosis"</a>.)</p><p class="headingAnchor" id="H17"><span class="h2">Systemic lupus erythematosus</span><span class="headingEndMark"> — </span>Enlargement of lymph nodes occurs in approximately 50 percent of patients with systemic lupus erythematosus (SLE). The nodes typically are soft; nontender; discrete; varying in size from 0.5 to several centimeters; and usually detected in the cervical, axillary, and inguinal areas. Lymphadenopathy is noted more frequently at the onset of disease or in association with an exacerbation. Lymph node enlargement also can be caused by infection or a lymphoproliferative disease in SLE; when infections are present, the enlarged nodes are more likely to be tender. (See  <a class="medical medical_review" href="/d/html/6420.html" rel="external">"Childhood-onset systemic lupus erythematosus (SLE): Clinical manifestations and diagnosis", section on 'Hematologic'</a>.)</p><p class="headingAnchor" id="H18"><span class="h2">Medications</span><span class="headingEndMark"> — </span>Numerous medications may cause serum sickness that is characterized by fever, arthralgias, rash, and generalized lymphadenopathy  (<a class="graphic graphic_table graphicRef71073" href="/d/graphic/71073.html" rel="external">table 2</a>). <a class="drug drug_pediatric" data-topicid="12702" href="/d/drug information/12702.html" rel="external">Phenytoin</a> can cause generalized lymphadenopathy in the absence of a serum sickness reaction. (See  <a class="medical medical_review" href="/d/html/2078.html" rel="external">"Serum sickness and serum sickness-like reactions"</a> and  <a class="medical medical_review" href="/d/html/2221.html" rel="external">"Antiseizure medications: Mechanism of action, pharmacology, and adverse effects", section on 'Phenytoin and fosphenytoin'</a> and  <a class="medical medical_review" href="/d/html/2089.html" rel="external">"Drug eruptions", section on 'Drug reaction with eosinophilia and systemic symptoms'</a>.)</p><p class="headingAnchor" id="H19"><span class="h1">UNCOMMON BUT IMPORTANT CAUSES</span><span class="headingEndMark"> — </span>Lymphadenopathy is a central feature of numerous less common systemic diseases that are important to consider because they are life-threatening or require specific treatment  (<a class="graphic graphic_table graphicRef81033 graphicRef66847" href="/d/graphic/81033.html" rel="external">table 1A-B</a> and <a class="graphic graphic_table graphicRef71073" href="/d/graphic/71073.html" rel="external">table 2</a>).</p><p class="headingAnchor" id="H20"><span class="h2">Malignancy</span><span class="headingEndMark"> — </span>Neoplastic causes of lymphadenopathy include Hodgkin disease, non-Hodgkin lymphoma, neuroblastoma, acute lymphocytic leukemia, acute myeloid leukemia, and rhabdomyosarcoma.</p><p>The prevalence of malignancy among patients seen in the primary care setting is relatively low [<a href="#rid4">4,5</a>]. In contrast, the prevalence of malignancy in lymph node biopsies performed in pediatric referral centers ranges from 13 to 27 percent [<a href="#rid3">3,6,7</a>]. Fever, duration of adenopathy, tenderness, bilaterality, skin rashes, and splenomegaly are not particularly helpful in discriminating between malignancy and other etiologies [<a href="#rid7">7</a>]. However, a higher incidence of cancer is expected in patients with certain clinical characteristics  (<a class="graphic graphic_table graphicRef106127" href="/d/graphic/106127.html" rel="external">table 4</a>). We recommend immediate biopsy or diagnostic evaluation for serious underlying cause for patients who have these findings. Additional indications for lymph node biopsy are discussed separately. (See  <a class="medical medical_review" href="/d/html/2867.html" rel="external">"Peripheral lymphadenopathy in children: Evaluation and diagnostic approach", section on 'Lymph node biopsy'</a>.)</p><p class="headingAnchor" id="H21"><span class="h2">Kawasaki disease</span><span class="headingEndMark"> — </span>Kawasaki disease is the most frequent cause of childhood vasculitis. This syndrome is associated with fever, cervical lymphadenopathy, and a variety of other manifestations, including conjunctivitis, mucositis, rash, and coronary artery aneurysms  (<a class="graphic graphic_table graphicRef67711" href="/d/graphic/67711.html" rel="external">table 5</a>). (See  <a class="medical medical_review" href="/d/html/6417.html" rel="external">"Kawasaki disease: Clinical features and diagnosis"</a>.)</p><p class="headingAnchor" id="H2438556833"><span class="h2">COVID-19 multisystem inflammatory syndrome in children</span><span class="headingEndMark"> — </span>Children with multisystem inflammatory syndrome in children (MIS-C) may present with cervical lymphadenopathy in addition to the more prevalent Kawasaki-disease-like features of fever, rash, mucous membrane involvement, and conjunctival injection. (See  <a class="medical medical_review" href="/d/html/128190.html" rel="external">"COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis", section on 'Presenting symptoms'</a>.)</p><p class="headingAnchor" id="H22"><span class="h2">Tularemia</span><span class="headingEndMark"> — </span>Patients with tularemia typically present with fever and a single erythematous papuloulcerative lesion with a central eschar  (<a class="graphic graphic_picture graphicRef51005" href="/d/graphic/51005.html" rel="external">picture 3</a>) that is accompanied by tender regional lymphadenopathy  (<a class="graphic graphic_picture graphicRef52036" href="/d/graphic/52036.html" rel="external">picture 4</a>). (See  <a class="medical medical_review" href="/d/html/3141.html" rel="external">"Tularemia: Clinical manifestations, diagnosis, treatment, and prevention", section on 'Clinical manifestations'</a>.)</p><p>The majority of cases in the United States occur in the central United States (eg, Arkansas, Missouri, Kansas, Nebraska, and Oklahoma)  (<a class="graphic graphic_figure graphicRef68457" href="/d/graphic/68457.html" rel="external">figure 3</a>). (See  <a class="medical medical_review" href="/d/html/3130.html" rel="external">"Tularemia: Microbiology, epidemiology, and pathogenesis", section on 'Geographic distribution'</a>.)</p><p>Sources of infections in humans include vectors (eg, ticks, biting flies, and mosquitoes), handling of infected animals (rodents and rabbits), ingestion of inadequately cooked meat, drinking contaminated water, cat scratches or bites, or splashing infected material into the eye or rubbing eyes with contaminated fingers. (See  <a class="medical medical_review" href="/d/html/3130.html" rel="external">"Tularemia: Microbiology, epidemiology, and pathogenesis", section on 'Routes of transmission'</a>.)</p><p class="headingAnchor" id="H23"><span class="h2">Langerhans cell histiocytosis</span><span class="headingEndMark"> — </span>Langerhans cell histiocytosis (LCH) may present with unilateral or bilateral cervical lymph nodes. Additional clinical manifestations of LCH may include lytic bone lesions, skin lesions, and hepatosplenomegaly. (See  <a class="medical medical_review" href="/d/html/8385.html" rel="external">"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis"</a>.)</p><p>Sometimes there is massive enlargement similar to those seen in Rosai-Dorfman disease. (See <a class="local">'Rosai-Dorfman disease'</a> below.)</p><p class="headingAnchor" id="H24"><span class="h2">Hemophagocytic lymphohistiocytosis</span><span class="headingEndMark"> — </span>Hemophagocytic lymphohistiocytosis (HLH) patients have diffuse adenopathy in one-third of cases. Additional clinical manifestations of HLH may include fever, hepatosplenomegaly, neurologic symptoms, and skin lesions. (See  <a class="medical medical_review" href="/d/html/87499.html" rel="external">"Clinical features and diagnosis of hemophagocytic lymphohistiocytosis", section on 'Clinical features'</a>.)</p><p class="headingAnchor" id="H25"><span class="h2">Chronic granulomatous disease</span><span class="headingEndMark"> — </span>Chronic granulomatous disease encompasses a heterogeneous group of disorders characterized by genetic defects in the ability of phagocytes to generate reactive oxygen intermediates from molecular oxygen. These defects manifest primarily as an immunodeficiency resulting in frequent, severe infections, including pneumonia, abscesses, suppurative adenitis, osteomyelitis, bacteremia/fungemia, and superficial skin infections (cellulitis/impetigo). (See  <a class="medical medical_review" href="/d/html/3925.html" rel="external">"Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis", section on 'Clinical manifestations'</a>.)</p><p class="headingAnchor" id="H26"><span class="h2">Castleman disease</span><span class="headingEndMark"> — </span>Multicentric Castleman disease is an uncommon lymphoproliferative disorder characterized by massive lymphadenopathy and systemic features such as fever, hepatomegaly, splenomegaly, and polyclonal hypergammaglobulinemia. Anemia is a common associated finding. (See  <a class="medical medical_review" href="/d/html/4707.html" rel="external">"HHV-8/KSHV-associated multicentric Castleman disease"</a>.)</p><p>Unicentric Castleman disease affects only one lymph node and is rarely associated with systemic features. (See  <a class="medical medical_review" href="/d/html/90340.html" rel="external">"Unicentric Castleman disease"</a>.)</p><p class="headingAnchor" id="H27"><span class="h2">Autoimmune lymphoproliferative disease</span><span class="headingEndMark"> — </span>Patients with autoimmune lymphoproliferative disease (ALPS), also known as the Canale-Smith syndrome or autoimmunity/lymphoproliferation syndrome, usually present in the first year of life with massive cervical adenopathy that may obscure the angle of the jaw [<a href="#rid18">18</a>]. Splenomegaly also can occur. Frequent associations with autoimmune diseases, including hemolytic anemia, neutropenia, immune thrombocytopenia, glomerulonephritis, and Guillain-Barré syndrome, have been reported. The syndrome appears to be caused by a defect in lymphocyte apoptosis (programmed cell death). (See  <a class="medical medical_review" href="/d/html/16361.html" rel="external">"Autoimmune lymphoproliferative syndrome (ALPS): Epidemiology and pathogenesis"</a> and  <a class="medical medical_review" href="/d/html/16837.html" rel="external">"Autoimmune lymphoproliferative syndrome (ALPS): Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/16614.html" rel="external">"Autoimmune lymphoproliferative syndrome (ALPS): Management and prognosis"</a>.)</p><p class="headingAnchor" id="H28"><span class="h2">Rosai-Dorfman disease</span><span class="headingEndMark"> — </span>Rosai-Dorfman disease (also known as Rosai-Dorfman-Destombes disease and sinus histiocytosis with massive lymphadenopathy) is a rare non-Langerhans cell histiocytosis [<a href="#rid19">19</a>]. It often presents with markedly enlarged, nontender cervical adenopathy of massive proportions, similar to ALPS [<a href="#rid20">20-24</a>]. However, other nodal sites, including the mediastinum, retroperitoneal, axillary, and inguinal sites, also may be involved. Other manifestations include involvement of the nasal cavity, salivary gland tissue and other regions of the head and neck, lytic bone lesions, pulmonary nodules, or rash [<a href="#rid25">25</a>]. Patients often are febrile when massive lymphadenopathy is present. Laboratory evaluations show leukocytosis, polyclonal hypergammaglobulinemia, a hypochromic or normocytic anemia, and elevated ESR. Treatment is variable depending upon involvement of other nodal areas. <a class="drug drug_pediatric" data-topicid="12924" href="/d/drug information/12924.html" rel="external">Clofarabine</a> has been especially effective for patients with bone and orbital involvement [<a href="#rid26">26</a>]. Spontaneous resolution may be observed but can take many months if not years [<a href="#rid24">24</a>]. <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fashpublications.org%2Fblood%2Farticle%2F131%2F26%2F2877%2F39185%2FConsensus-recommendations-for-the-diagnosis-and&amp;token=28%2B5MR4ohoqWhNO59Io36SYSg7jtCrXykiERFk2NyopGWziQgdEs3ws%2FNao1JfvXqacLXQ73a6YOhl8mLQEr2VniwOBDr86VhX8Pf8BD4%2F1PqtgMjLBHKs4C%2BqXJSs%2FXrOzI5zFL9R2kaV2HWb4jZw%3D%3D&amp;TOPIC_ID=2871" target="_blank">International consensus guidelines</a> for the diagnosis and management of Rosai-Dorfman disease provide guidelines for evaluation and treatment [<a href="#rid19">19</a>].</p><p class="headingAnchor" id="H29"><span class="h2">Kikuchi disease</span><span class="headingEndMark"> — </span>Kikuchi disease is a rare, benign condition of unknown cause usually characterized by cervical lymphadenopathy (although it may be more generalized) and fever. It is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/5507.html" rel="external">"Kikuchi disease"</a>.)</p><p class="headingAnchor" id="H348678369"><span class="h2">Kimura disease</span><span class="headingEndMark"> — </span>Kimura disease,<strong> </strong>another rare cause of cervical lymphadenopathy, is characterized by a triad of painless subcutaneous masses in the head and neck with lymphadenopathy, blood and tissue eosinophilia, and markedly increased serum immunoglobulin E [<a href="#rid27">27</a>]. (See  <a class="medical medical_review" href="/d/html/90449.html" rel="external">"Angiolymphoid hyperplasia with eosinophilia and Kimura disease", section on 'Kimura disease'</a>.)</p><p class="headingAnchor" id="H30"><span class="h2">Inflammatory pseudotumor</span><span class="headingEndMark"> — </span>Inflammatory pseudotumor of lymph nodes is a syndrome of lymphadenopathy in one or more node groups, often with systemic symptoms. Nodes show a fibrosing and inflammatory process [<a href="#rid28">28</a>].</p><p class="headingAnchor" id="H32"><span class="h2">Sarcoidosis</span><span class="headingEndMark"> — </span>Children with sarcoidosis may present with impressive cervical adenopathy, similar to ALPS or Rosai-Dorfman disease patients. Lymphadenopathy is present in 50 percent of patients with sarcoidosis, who often have weight loss, cough, fatigue, lethargy, bone and joint pain, anorexia, and headache [<a href="#rid29">29</a>]. (See  <a class="medical medical_review" href="/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis"</a> and  <a class="medical medical_review" href="/d/html/91259.html" rel="external">"Overview of extrapulmonary manifestations of sarcoidosis"</a>.)</p><p class="headingAnchor" id="H33"><span class="h1">MIMICS OF LYMPHADENOPATHY</span><span class="headingEndMark"> — </span>Conditions that can mimic an enlarged lymph node are listed below [<a href="#rid16">16,30-32</a>]. In most cases, these conditions can be differentiated from lymphadenopathy by the history and examination.</p><p class="bulletIndent1"><span class="glyph">●</span>Infection or stones in any of the salivary glands (see  <a class="medical medical_review" href="/d/html/8310.html" rel="external">"Mumps"</a> and  <a class="medical medical_review" href="/d/html/6854.html" rel="external">"Salivary gland stones"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Congenital anomalies: branchial cleft cyst, cystic hygroma  (<a class="graphic graphic_picture graphicRef105718" href="/d/graphic/105718.html" rel="external">picture 5</a>), thyroglossal duct cyst (see  <a class="medical medical_review" href="/d/html/5789.html" rel="external">"Vascular lesions in the newborn", section on 'Macrocystic lymphatic malformation (cystic hygroma)'</a> and  <a class="medical medical_review" href="/d/html/2155.html" rel="external">"Thyroglossal duct cyst, thyroglossal duct cyst cancer, and ectopic thyroid"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Thyroid nodule (see  <a class="medical medical_review" href="/d/html/5835.html" rel="external">"Thyroid nodules and cancer in children"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Soft-tissue swelling from trauma or an insect bite or sting</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hematoma</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inguinal hernia (see  <a class="medical medical_review" href="/d/html/6476.html" rel="external">"Inguinal hernia in children"</a> and  <a class="medical medical_review" href="/d/html/13883.html" rel="external">"Evaluation of inguinal swelling in children", section on 'Causes of inguinal swelling'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Undescended testicle (see  <a class="medical medical_review" href="/d/html/2850.html" rel="external">"Undescended testes (cryptorchidism) in children: Clinical features and evaluation", section on 'Clinical features'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hemangioma, lymphangioma (see  <a class="medical medical_review" href="/d/html/5794.html" rel="external">"Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications", section on 'Clinical presentation'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Lipoma</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dermoid (see  <a class="medical medical_review" href="/d/html/5788.html" rel="external">"Skin nodules in newborns and infants", section on 'Dermoid cysts and sinuses'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rheumatoid nodules (see  <a class="medical medical_review" href="/d/html/7523.html" rel="external">"Rheumatoid nodules"</a>)</p><p></p><p class="headingAnchor" id="H165764131"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient education" and the keyword[s] of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/17190.html" rel="external">"Patient education: Swollen neck nodes in children (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H34"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anatomy and definitions</strong> – Normal lymph nodes in most regions usually are less than 1 cm in their longest diameter; normal lymph nodes in the epitrochlear region usually are less than 0.5 cm, and normal lymph nodes in the inguinal region usually are less than 1.5 cm. (See <a class="local">'Anatomy and definitions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General classification</strong> – Lymphadenopathy can be caused by a vast array of diseases  (<a class="graphic graphic_table graphicRef81033 graphicRef66847" href="/d/graphic/81033.html" rel="external">table 1A-B</a> and <a class="graphic graphic_table graphicRef71073" href="/d/graphic/71073.html" rel="external">table 2</a>) and drugs  (<a class="graphic graphic_table graphicRef61046" href="/d/graphic/61046.html" rel="external">table 3</a>). It is clinically useful to classify the causes of lymphadenopathy according to whether the lymphadenopathy is localized or generalized. (See <a class="local">'General classification'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Localized lymphadenopathy</strong> – Localized lymphadenopathy is present in only one region  (<a class="graphic graphic_table graphicRef71073" href="/d/graphic/71073.html" rel="external">table 2</a>). (See <a class="local">'Localized lymphadenopathy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Generalized lymphadenopathy</strong> – Generalized lymphadenopathy is present in two or more noncontiguous regions  (<a class="graphic graphic_table graphicRef81033 graphicRef66847" href="/d/graphic/81033.html" rel="external">table 1A-B</a>). (See <a class="local">'Generalized lymphadenopathy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Uncommon but important causes of lymphadenopathy</strong> – Uncommon but important causes of peripheral lymphadenopathy in children include (see <a class="local">'Uncommon but important causes'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Malignancy</p><p></p><p class="bulletIndent2">Malignancy should be considered in children with peripheral lymphadenopathy and worrisome features  (<a class="graphic graphic_table graphicRef106127" href="/d/graphic/106127.html" rel="external">table 4</a>). Immediate lymph node biopsy is indicated in such children. Additional indications for biopsy are discussed separately. (See <a class="local">'Malignancy'</a> above and  <a class="medical medical_review" href="/d/html/2867.html" rel="external">"Peripheral lymphadenopathy in children: Evaluation and diagnostic approach", section on 'Lymph node biopsy'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Kawasaki disease  (<a class="graphic graphic_table graphicRef67711" href="/d/graphic/67711.html" rel="external">table 5</a>) (see  <a class="medical medical_review" href="/d/html/6417.html" rel="external">"Kawasaki disease: Clinical features and diagnosis"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>COVID-19 multisystem inflammatory syndrome in children (see  <a class="medical medical_review" href="/d/html/128190.html" rel="external">"COVID-19: Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis", section on 'Presenting symptoms'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Tularemia  (<a class="graphic graphic_picture graphicRef52036" href="/d/graphic/52036.html" rel="external">picture 4</a>) (see  <a class="medical medical_review" href="/d/html/3141.html" rel="external">"Tularemia: Clinical manifestations, diagnosis, treatment, and prevention", section on 'Clinical manifestations'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Langerhans cell histiocytosis (see  <a class="medical medical_review" href="/d/html/8385.html" rel="external">"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hemophagocytic lymphohistiocytosis (see  <a class="medical medical_review" href="/d/html/87499.html" rel="external">"Clinical features and diagnosis of hemophagocytic lymphohistiocytosis", section on 'Clinical features'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Chronic granulomatous disease (see  <a class="medical medical_review" href="/d/html/3925.html" rel="external">"Chronic granulomatous disease: Pathogenesis, clinical manifestations, and diagnosis", section on 'Clinical manifestations'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Castleman disease (see  <a class="medical medical_review" href="/d/html/4707.html" rel="external">"HHV-8/KSHV-associated multicentric Castleman disease"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Autoimmune lymphoproliferative disease (see  <a class="medical medical_review" href="/d/html/16837.html" rel="external">"Autoimmune lymphoproliferative syndrome (ALPS): Clinical features and diagnosis", section on 'Clinical manifestations of ALPS-FAS'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Rosai-Dorfman disease</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Kikuchi disease (see  <a class="medical medical_review" href="/d/html/5507.html" rel="external">"Kikuchi disease"</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Kimura disease (see  <a class="medical medical_review" href="/d/html/90449.html" rel="external">"Angiolymphoid hyperplasia with eosinophilia and Kimura disease", section on 'Kimura disease'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Inflammatory pseudotumor</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Sarcoidosis (see  <a class="medical medical_review" href="/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis"</a> and  <a class="medical medical_review" href="/d/html/91259.html" rel="external">"Overview of extrapulmonary manifestations of sarcoidosis"</a>)</p><p></p><p class="headingAnchor" id="H388654853"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Robert H Fletcher, MD, MSc, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Jackson MA, Day JC. Lymphatic system and generalized lymphadenopathy. In: Principles and Practice of Pediatric Infectious Diseases, 5th ed, Long SS, Prober CG, Fischer M (Eds), Elsevier, Philadelphia 2018. p.128.</li><li><a class="nounderline abstract_t">Herzog LW. Prevalence of lymphadenopathy of the head and neck in infants and children. Clin Pediatr (Phila) 1983; 22:485.</a></li><li><a class="nounderline abstract_t">Knight PJ, Mulne AF, Vassy LE. When is lymph node biopsy indicated in children with enlarged peripheral nodes? Pediatrics 1982; 69:391.</a></li><li><a class="nounderline abstract_t">Ferrer R. Lymphadenopathy: differential diagnosis and evaluation. Am Fam Physician 1998; 58:1313.</a></li><li><a class="nounderline abstract_t">HEINRICH WA, JUDD ES Jr. A critical analysis of biopsy of lymph nodes. Proc Staff Meet Mayo Clin 1948; 23:465.</a></li><li><a class="nounderline abstract_t">Lake AM, Oski FA. Peripheral lymphadenopathy in childhood. Ten-year experience with excisional biopsy. Am J Dis Child 1978; 132:357.</a></li><li><a class="nounderline abstract_t">Soldes OS, Younger JG, Hirschl RB. Predictors of malignancy in childhood peripheral lymphadenopathy. J Pediatr Surg 1999; 34:1447.</a></li><li><a class="nounderline abstract_t">Celenk F, Gulsen S, Baysal E, et al. Predictive factors for malignancy in patients with persistent cervical lymphadenopathy. Eur Arch Otorhinolaryngol 2016; 273:251.</a></li><li><a class="nounderline abstract_t">Deosthali A, Donches K, DelVecchio M, Aronoff S. Etiologies of Pediatric Cervical Lymphadenopathy: A Systematic Review of 2687 Subjects. Glob Pediatr Health 2019; 6:2333794X19865440.</a></li><li><a class="nounderline abstract_t">Barton LL, Feigin RD. Childhood cervical lymphadenitis: a reappraisal. J Pediatr 1974; 84:846.</a></li><li><a class="nounderline abstract_t">Williamson HA Jr. Lymphadenopathy in a family practice: a descriptive study of 249 cases. J Fam Pract 1985; 20:449.</a></li><li><a class="nounderline abstract_t">Lai KK, Stottmeier KD, Sherman IH, McCabe WR. Mycobacterial cervical lymphadenopathy. Relation of etiologic agents to age. JAMA 1984; 251:1286.</a></li><li><a class="nounderline abstract_t">Spark RP, Fried ML, Bean CK, et al. Nontuberculous mycobacterial adenitis of childhood. The ten-year experience at a community hospital. Am J Dis Child 1988; 142:106.</a></li><li><a class="nounderline abstract_t">Gaines H, von Sydow M, Pehrson PO, Lundbegh P. Clinical picture of primary HIV infection presenting as a glandular-fever-like illness. BMJ 1988; 297:1363.</a></li><li><a class="nounderline abstract_t">Abramson SJ, Berdon WE, Stolar C, et al. Stage IVN neuroblastoma: MRI diagnosis of left supraclavicular "Virchow's" nodal spread. Pediatr Radiol 1996; 26:717.</a></li><li><a class="nounderline abstract_t">Hamilton W, Pascoe J, John J, et al. Diagnosing groin lumps. BMJ 2021; 372:n578.</a></li><li><a class="nounderline abstract_t">Yatabe R, Iio K, Uda K, Hataya H. Acute Inguinal Bacterial Lymphadenitis in Infants Younger Than 1 Year of Age. Pediatr Infect Dis J 2021; 40:e450.</a></li><li><a class="nounderline abstract_t">Sneller MC, Wang J, Dale JK, et al. Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood 1997; 89:1341.</a></li><li><a class="nounderline abstract_t">Abla O, Jacobsen E, Picarsic J, et al. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood 2018; 131:2877.</a></li><li><a class="nounderline abstract_t">McAlister WH, Herman T, Dehner LP. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Pediatr Radiol 1990; 20:425.</a></li><li><a class="nounderline abstract_t">Horneff G, Jürgens H, Hort W, et al. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): response to methotrexate and mercaptopurine. Med Pediatr Oncol 1996; 27:187.</a></li><li><a class="nounderline abstract_t">Pulsoni A, Anghel G, Falcucci P, et al. Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a case and literature review. Am J Hematol 2002; 69:67.</a></li><li><a class="nounderline abstract_t">La Barge DV 3rd, Salzman KL, Harnsberger HR, et al. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): imaging manifestations in the head and neck. AJR Am J Roentgenol 2008; 191:W299.</a></li><li><a class="nounderline abstract_t">Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol 1990; 7:19.</a></li><li><a class="nounderline abstract_t">Raslan OA, Schellingerhout D, Fuller GN, Ketonen LM. Rosai-Dorfman disease in neuroradiology: imaging findings in a series of 10 patients. AJR Am J Roentgenol 2011; 196:W187.</a></li><li><a class="nounderline abstract_t">Simko SJ, Tran HD, Jones J, et al. Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease. Pediatr Blood Cancer 2014; 61:479.</a></li><li><a class="nounderline abstract_t">Mrówka-Kata K, Kata D, Kyrcz-Krzemień S, Helbig G. Kikuchi-Fujimoto and Kimura diseases: the selected, rare causes of neck lymphadenopathy. Eur Arch Otorhinolaryngol 2010; 267:5.</a></li><li><a class="nounderline abstract_t">Moran CA, Suster S, Abbondanzo SL. Inflammatory pseudotumor of lymph nodes: a study of 25 cases with emphasis on morphological heterogeneity. Hum Pathol 1997; 28:332.</a></li><li><a class="nounderline abstract_t">Pattishall EN, Strope GL, Spinola SM, Denny FW. Childhood sarcoidosis. J Pediatr 1986; 108:169.</a></li><li><a class="nounderline abstract_t">Torsiglieri AJ Jr, Tom LW, Ross AJ 3rd, et al. Pediatric neck masses: guidelines for evaluation. Int J Pediatr Otorhinolaryngol 1988; 16:199.</a></li><li><a class="nounderline abstract_t">Margileth AM. Sorting out the causes of lymphadenopathy. Contemp Pediatr 1995; 12:23.</a></li><li><a class="nounderline abstract_t">Yaris N, Cakir M, Sözen E, Cobanoglu U. Analysis of children with peripheral lymphadenopathy. Clin Pediatr (Phila) 2006; 45:544.</a></li></ol></div><div id="topicVersionRevision">Topic 2871 Version 31.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Jackson MA, Day JC. Lymphatic system and generalized lymphadenopathy. In: Principles and Practice of Pediatric Infectious Diseases, 5th ed, Long SS, Prober CG, Fischer M (Eds), Elsevier, Philadelphia 2018. p.128.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6851374" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Prevalence of lymphadenopathy of the head and neck in infants and children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7070884" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : When is lymph node biopsy indicated in children with enlarged peripheral nodes?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9803196" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Lymphadenopathy: differential diagnosis and evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18888946" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : A critical analysis of biopsy of lymph nodes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/645650" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Peripheral lymphadenopathy in childhood. Ten-year experience with excisional biopsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10549745" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Predictors of malignancy in childhood peripheral lymphadenopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26187739" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Predictive factors for malignancy in patients with persistent cervical lymphadenopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31384630" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Etiologies of Pediatric Cervical Lymphadenopathy: A Systematic Review of 2687 Subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4826618" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Childhood cervical lymphadenitis: a reappraisal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3989485" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Lymphadenopathy in a family practice: a descriptive study of 249 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6422062" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Mycobacterial cervical lymphadenopathy. Relation of etiologic agents to age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3257636" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Nontuberculous mycobacterial adenitis of childhood. The ten-year experience at a community hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3146367" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Clinical picture of primary HIV infection presenting as a glandular-fever-like illness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8805603" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Stage IVN neuroblastoma: MRI diagnosis of left supraclavicular "Virchow's" nodal spread.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33712475" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Diagnosing groin lumps.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34636802" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Acute Inguinal Bacterial Lymphadenitis in Infants Younger Than 1 Year of Age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9028957" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29720485" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2202971" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8699998" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): response to methotrexate and mercaptopurine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11835335" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a case and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19020219" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): imaging manifestations in the head and neck.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2180012" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21257861" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Rosai-Dorfman disease in neuroradiology: imaging findings in a series of 10 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24106153" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19834725" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Kikuchi-Fujimoto and Kimura diseases: the selected, rare causes of neck lymphadenopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9042798" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Inflammatory pseudotumor of lymph nodes: a study of 25 cases with emphasis on morphological heterogeneity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3944700" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Childhood sarcoidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3235286" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Pediatric neck masses: guidelines for evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Sorting out the causes of lymphadenopathy</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16893860" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Analysis of children with peripheral lymphadenopathy.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
